Nearly half of the respondents in NNIT’s Expectation Barometer 2023 survey place heightened integration of AI at the top of their priority list. However, prior to fully embracing AI, life sciences companies should prioritize the people and business processes that will become AI’s closest allies.
Artificial intelligence (AI) has moved into the public sector, and the Danish authorities are exploring how the technology can become a valuable tool. According to NNIT's Jannic Stolzenbach Jensen, transparency and human supervision will be crucial in ensuring that AI can improve welfare.
Like the rest of the world, the life sciences industry is right in the eye of a raging storm of multiple rapid changes. According to Ricco Larsen, Senior Vice President at NNIT, the top priority for pharma companies is to invest in a solid data foundation so they are fully prepared for what comes next.
The potential benefits of an electronic Trial Master File (eTMF) system extend far beyond clinical operations. As Tróndur Ellingsgaard, Advisory Consultant at NNIT explains, a mature eTMF can enhance efficiency, foster greater collaboration across the organization, and enable informed decision-making.
Implementing an electronic Trial Master File (eTMF) system can revolutionize the way clinical trials are managed. However, as Michael Agard, Director of Clinical Consulting at NNIT, points out, the true value of eTMF lies in post-implementation management.
When public authorities base their IT tenders on the standards set by FDA (Fællesoffentlig Digital Arkitektur), the risk is that they will get IT systems that do not match the complex requirements of public case-handling, so say two NNIT public IT experts.
